atc_code
stringlengths 1
7
| atc_description
stringlengths 3
113
| atc_level
int64 1
5
| atc_parent_code
stringlengths 1
5
⌀ | schedule_code
int64 3.67k
3.67k
|
---|---|---|---|---|
V09HA01
|
technetium (99mTc) human immunoglobulin
| 5 |
V09HA
| 3,671 |
V09HA02
|
technetium (99mTc) exametazime labelled cells
| 5 |
V09HA
| 3,671 |
V09HA03
|
technetium (99mTc) antigranulocyte antibody
| 5 |
V09HA
| 3,671 |
V09HA04
|
technetium (99mTc) sulesomab
| 5 |
V09HA
| 3,671 |
V09HB
|
Indium (111In) compounds
| 4 |
V09H
| 3,671 |
V09HB01
|
indium (111In) oxinate labelled cells
| 5 |
V09HB
| 3,671 |
V09HB02
|
indium (111In) tropolonate labelled cells
| 5 |
V09HB
| 3,671 |
V09HX
|
Other diagnostic radiopharmaceuticals for inflammation and infection detection
| 4 |
V09H
| 3,671 |
V09HX01
|
gallium (67Ga) citrate
| 5 |
V09HX
| 3,671 |
V09I
|
TUMOUR DETECTION
| 3 |
V09
| 3,671 |
V09IA
|
Technetium (99mTc) compounds
| 4 |
V09I
| 3,671 |
V09IA01
|
technetium (99mTc) antiCarcinoEmbryonicAntigen antibody
| 5 |
V09IA
| 3,671 |
V09IA02
|
technetium (99mTc) antimelanoma antibody
| 5 |
V09IA
| 3,671 |
V09IA03
|
technetium (99mTc) pentavalent succimer
| 5 |
V09IA
| 3,671 |
V09IA04
|
technetium (99mTc) votumumab
| 5 |
V09IA
| 3,671 |
V09IA05
|
technetium (99mTc) depreotide
| 5 |
V09IA
| 3,671 |
V09IA06
|
technetium (99mTc) arcitumomab
| 5 |
V09IA
| 3,671 |
V09IA07
|
technetium (99mTc) hynic-octreotide
| 5 |
V09IA
| 3,671 |
V09IA08
|
technetium (99mTc) etarfolatide
| 5 |
V09IA
| 3,671 |
V09IA09
|
technetium (99mTc) tilmanocept
| 5 |
V09IA
| 3,671 |
V09IA10
|
technetium (99mTc) trofolastat chloride
| 5 |
V09IA
| 3,671 |
V09IB
|
Indium (111In) compounds
| 4 |
V09I
| 3,671 |
V09IB01
|
indium (111In) pentetreotide
| 5 |
V09IB
| 3,671 |
V09IB02
|
indium (111In) satumomab pendetide
| 5 |
V09IB
| 3,671 |
V09IB03
|
indium (111In) antiovariumcarcinoma antibody
| 5 |
V09IB
| 3,671 |
V09IB04
|
indium (111In) capromab pendetide
| 5 |
V09IB
| 3,671 |
V09IX
|
Other diagnostic radiopharmaceuticals for tumour detection
| 4 |
V09I
| 3,671 |
V09IX01
|
iobenguane (123I)
| 5 |
V09IX
| 3,671 |
V09IX02
|
iobenguane (131I)
| 5 |
V09IX
| 3,671 |
V09IX03
|
iodine (125I) CC49-monoclonal antibody
| 5 |
V09IX
| 3,671 |
V09IX04
|
fludeoxyglucose (18F)
| 5 |
V09IX
| 3,671 |
V09IX05
|
fluorodopa (18F)
| 5 |
V09IX
| 3,671 |
V09IX06
|
sodium fluoride (18F)
| 5 |
V09IX
| 3,671 |
V09IX07
|
fluorocholine (18F)
| 5 |
V09IX
| 3,671 |
V09IX08
|
fluoroethylcholine (18F)
| 5 |
V09IX
| 3,671 |
V09IX09
|
gallium (68Ga) edotreotide
| 5 |
V09IX
| 3,671 |
V09IX10
|
fluoroethyl-L-tyrosine (18F)
| 5 |
V09IX
| 3,671 |
V09IX11
|
fluoroestradiol (18F)
| 5 |
V09IX
| 3,671 |
V09IX12
|
fluciclovine (18F)
| 5 |
V09IX
| 3,671 |
V09IX13
|
methionine (11C)
| 5 |
V09IX
| 3,671 |
V09IX14
|
gallium (68Ga) gozetotide
| 5 |
V09IX
| 3,671 |
V09IX15
|
copper (64Cu) dotatate
| 5 |
V09IX
| 3,671 |
V09IX16
|
piflufolastat (18F)
| 5 |
V09IX
| 3,671 |
V09IX17
|
PSMA-1007 (18F)
| 5 |
V09IX
| 3,671 |
V09IX18
|
flotufolastat (18F)
| 5 |
V09IX
| 3,671 |
V09X
|
OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
| 3 |
V09
| 3,671 |
V09XA
|
Iodine (131I) compounds
| 4 |
V09X
| 3,671 |
V09XA01
|
iodine (131I) norcholesterol
| 5 |
V09XA
| 3,671 |
V09XA02
|
iodocholesterol (131I)
| 5 |
V09XA
| 3,671 |
V09XA03
|
iodine (131I) human albumin
| 5 |
V09XA
| 3,671 |
V09XX
|
Various diagnostic radiopharmaceuticals
| 4 |
V09X
| 3,671 |
V09XX01
|
cobalt (57Co) cyanocobalamine
| 5 |
V09XX
| 3,671 |
V09XX02
|
cobalt (58Co) cyanocobalamine
| 5 |
V09XX
| 3,671 |
V09XX03
|
selenium (75Se) norcholesterol
| 5 |
V09XX
| 3,671 |
V09XX04
|
ferric (59Fe) citrate
| 5 |
V09XX
| 3,671 |
V10
|
THERAPEUTIC RADIOPHARMACEUTICALS
| 2 |
V
| 3,671 |
V10A
|
ANTIINFLAMMATORY AGENTS
| 3 |
V10
| 3,671 |
V10AA
|
Yttrium (90Y) compounds
| 4 |
V10A
| 3,671 |
V10AA01
|
yttrium (90Y) citrate colloid
| 5 |
V10AA
| 3,671 |
V10AA02
|
yttrium (90Y) ferrihydroxide colloid
| 5 |
V10AA
| 3,671 |
V10AA03
|
yttrium (90Y) silicate colloid
| 5 |
V10AA
| 3,671 |
V10AB
|
HOMEOPATHIC PRODUCTS WITH THERAPEUTIC CLAIMS
| 4 |
V10A
| 3,671 |
V10AX
|
Other antiinflammatory therapeutic radiopharmaceuticals
| 4 |
V10A
| 3,671 |
V10AX01
|
phosphorous (32P) chromicphosphate colloid
| 5 |
V10AX
| 3,671 |
V10AX02
|
samarium (153Sm) hydroxyapatite colloid
| 5 |
V10AX
| 3,671 |
V10AX03
|
dysprosium (165Dy) colloid
| 5 |
V10AX
| 3,671 |
V10AX04
|
erbium (169Er) citrate colloid
| 5 |
V10AX
| 3,671 |
V10AX05
|
rhenium (186Re) sulfide colloid
| 5 |
V10AX
| 3,671 |
V10AX06
|
gold (198Au) colloidal
| 5 |
V10AX
| 3,671 |
V10B
|
PAIN PALLIATION (BONE SEEKING AGENTS)
| 3 |
V10
| 3,671 |
V10BX
|
Various pain palliation radiopharmaceuticals
| 4 |
V10B
| 3,671 |
V10BX01
|
strontium (89Sr) chloride
| 5 |
V10BX
| 3,671 |
V10BX02
|
samarium (153Sm) lexidronam
| 5 |
V10BX
| 3,671 |
V10BX03
|
rhenium (186Re) etidronic acid
| 5 |
V10BX
| 3,671 |
V10X
|
OTHER THERAPEUTIC RADIOPHARMACEUTICALS
| 3 |
V10
| 3,671 |
V10XA
|
Iodine (131I) compounds
| 4 |
V10X
| 3,671 |
V10XA01
|
sodium iodide (131I)
| 5 |
V10XA
| 3,671 |
V10XA02
|
iobenguane (131I)
| 5 |
V10XA
| 3,671 |
V10XA03
|
iodine (131I) omburtamab
| 5 |
V10XA
| 3,671 |
V10XA04
|
iodine (131I) apamistamab
| 5 |
V10XA
| 3,671 |
V10XA53
|
tositumomab/iodine (131I) tositumomab
| 5 |
V10XA
| 3,671 |
V10XX
|
Various therapeutic radiopharmaceuticals
| 4 |
V10X
| 3,671 |
V10XX01
|
sodium phosphate (32P)
| 5 |
V10XX
| 3,671 |
V10XX02
|
ibritumomab tiuxetan (90Y)
| 5 |
V10XX
| 3,671 |
V10XX03
|
radium (223Ra) dichloride
| 5 |
V10XX
| 3,671 |
V10XX04
|
lutetium (177Lu) oxodotreotide
| 5 |
V10XX
| 3,671 |
V10XX05
|
lutetium (177Lu) vipivotide tetraxetan
| 5 |
V10XX
| 3,671 |
V20
|
SURGICAL DRESSINGS
| 2 |
V
| 3,671 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.